SCHEMBL19567412

SCHEMBL19567412

CC1(CC#N)CCC(NCc2cccc(F)c2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CARM1 Q86X55 2/20 0.50
▸ PRMT6 Q96LA8 2/20 0.50
▸ JAK2 O60674 6/20 0.46
▸ JAK1 P23458 6/20 0.46
▸ KCNH2 Q12809 1/20 0.43
▸ KDM1A O60341 2/20 0.41
▸ MAOB P27338 2/20 0.41
▸ MAOA P21397 1/20 0.41
▸ SLC6A2 P23975 1/20 0.41
▸ HRH2 P25021 1/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ SLC6A3 Q01959 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ OPRM1 P35372 2/20 0.40
▸ OPRL1 P41146 2/20 0.40
▸ POLB P06746 1/20 0.38
▸ ACHE P22303 1/20 0.37
▸ BACE1 P56817 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19567519 1.00 CARM1 (0.50) CARM1PRMT6JAK2JAK1KCNH2
SCHEMBL23514508 1.00 CARM1 (0.50) CARM1PRMT6JAK2JAK1KCNH2
SCHEMBL19567376 0.86 CARM1 (0.48) CARM1PRMT6JAK2JAK1KCNH2
SCHEMBL19567390 0.85 MAOA (0.47) JAK2JAK1KDM1AMAOBMAOA
SCHEMBL19567374 0.85 MAOA (0.47) JAK2JAK1KDM1AMAOBMAOA
SCHEMBL19567667 0.85 CARM1 (0.47) CARM1PRMT6JAK2JAK1KCNH2
SCHEMBL20782001 0.85 ALDH1A1 (0.38) CARM1PRMT6JAK2JAK1KCNH2
SCHEMBL19567521 0.85 CARM1 (0.47) CARM1PRMT6JAK2JAK1KCNH2
SCHEMBL19567880 0.85 JAK2 (0.44) JAK2JAK1ALDH1A1OPRM1OPRL1
SCHEMBL24092999 0.85 JAK2 (0.44) JAK2JAK1ALDH1A1OPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452464-B1 PYRAZOLE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USE THEREOF HOFFMANN LA ROCHE (CH) 2021-12-15 — — EP disclosed
WO-2017191098-A1 PYRAZOLE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-11-09 — — WO disclosed
Send feedback